Literature DB >> 30276431

[School-based tobacco prevention: the "Be Smart - Don't Start" program].

Barbara Isensee1, Reiner Hanewinkel2.   

Abstract

The competition for smoke-free classes, the "Be Smart - Don't Start" program has been implemented in Germany since 1997. Using contract management techniques, school classes participating in the competition commit themselves to abstain from smoking for six months. Classes report on a regular basis whether they have stayed smoke-free or not. After the end of the competition period, successful classes participate in a prize draw. The competition aimes to influence social norms.Over the past 20 years, the competition has become a major school-based intervention to prevent smoking in Germany. Several studies addressed process and outcome evaluation, cost-benefit efficacy and iatrogenic effects. Following the evidence so far, the intervention is feasible for implementation in school routines, evokes positive feedback in teachers and students, and reveals a positive cost-benefit ratio. Findings from controlled studies imply that negative side-effects are unlikely to occur and that participation in the competition affects the progression of smoking positively at least in the short term.

Entities:  

Keywords:  Adolescents; Competition; Evaluation; Smokefree Class

Mesh:

Year:  2018        PMID: 30276431     DOI: 10.1007/s00103-018-2825-9

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  2 in total

1.  [Smoke-free Germany 2040: a discussion paper].

Authors:  Reiner Hanewinkel; Matthis Morgenstern; Barbara Isensee; Friedrich J Wiebel
Journal:  Dtsch Med Wochenschr       Date:  2020-06-22       Impact factor: 0.628

2.  Effectiveness of an app-based intervention to reduce substance use, gambling, and digital media use in vocational school students: study protocol for a randomized controlled trial.

Authors:  Nicolas Arnaud; Johanna Weymann; Kirsten Lochbühler; Benjamin Pietsch; Monika Rossa; Ludwig Kraus; Rainer Thomasius; Reiner Hanewinkel; Matthis Morgenstern
Journal:  Trials       Date:  2022-04-08       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.